The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Top Cited Papers
- 1 October 2004
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics & Related Research
- Vol. 427, S27-S36
- https://doi.org/10.1097/01.blo.0000144854.66565.8f
Abstract
Chondrocytes are the single cellular component of hyaline cartilage. Under physiologic conditions, they show steady-state equilibrium between anabolic and catabolic activities that maintains the structural and functional integrity of the cartilage extracellular matrix. Implicit in the loss of cartilage matrix that is associated with osteoarthritis is that there is a disturbance in the regulation of synthetic (anabolic) and resorptive (catabolic) activities of the resident chondrocytes that results in a net loss of cartilage matrix components and deterioration in the structural and functional properties of the cartilage. Multiple mechanisms likely are involved in the disturbance of chondrocyte remodeling activities in OA. They include the development of acquired or age-related alterations in chondrocyte function, the effects of excessive mechanical loading, and the presence of dysregulated cytokine activities. Cytokines are soluble or cell-surface molecules that play an essential role in mediating cell-cell interactions. It is possible to classify the cytokines that regulate cartilage remodeling as catabolic, acting on target cells to increase products that enhance matrix degradation; as anticatabolic, tending to inhibit or antagonize the activity of the catabolic cytokines; and as anabolic, acting on chondrocytes to increase synthetic activity. This review will focus on the role of proinflammatory cytokines and their roles in mediating the increased matrix degradation that characterizes the osteoarthritic cartilage lesion.Keywords
This publication has 99 references indexed in Scilit:
- Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: Interaction with exogenous cytokinesArthritis & Rheumatism, 2003
- Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdownArthritis & Rheumatism, 2001
- T-cell mediated inflammatory pathway in osteoarthritisOsteoarthritis and Cartilage, 1999
- Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokinesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Antisense oligonucleotides, a novel tool for the control of cytokine effects on human cartilage. focus on interleukins 1 and 6 and proteoglycan synthesisArthritis & Rheumatism, 1994
- Transcriptional suppression by interleukin‐1 and interferon‐γ of type II collagen gene expression in human chondrocytesJournal of Cellular Biochemistry, 1994
- Induction of Nitric Oxide Synthase in Human ChondrocytesBiochemical and Biophysical Research Communications, 1993
- The effect of tumor necrosis factor α and γ‐interferon on the resorption of human articular cartilage and on the production of prostaglandin e and of caseinase activity by human articular chondrocytesArthritis & Rheumatism, 1989
- Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1β or phorbol esterBiochemical and Biophysical Research Communications, 1987
- Cloning and expression of murine interleukin-1 cDNA in Escherichia coliNature, 1984